Bulk Supply IGF LR/Retatrutide/Cagri/Tirze/Ghk-Cu Peptide for Weight Loss 5mg 10 mg 15mg Vial
56 Inquiries
946870-92-4
Pharmaceutical Grade
99%
Shenzhen
CQ
0.1mg/vial; 10vials/box
2026-08-31
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceLong arginine 3-IGF-1, abbreviated as IGF-1 LR3 or LR3-IGF-1, is a synthetic protein and lengthened analogue of human insulin-like growth factor 1 (IGF-1). It differs from native IGF-1 in that it possesses an arginine instead of a glutamic acid at the third position in its amino acid sequence ("arginine 3"), and also has an additional 13 amino acids at its N-terminus (MFPAMPLLSLFVN) ("long"), for a total of 83 amino acids (relative to the 70 of IGF-1).Basic Info
-
Product Name:
IGF-1 LR3
Other Name:IGF-1 LR3;CL281;LR3-IGF1;IGF-1Lr3 Igtropin;LR3-IGF1 (100mcg/vial;IGF LR3-1;IDF-1 LR3;Recombinant Human Insulin-like Growth Factor-1 LR3, rhIGF-1
CAS No.:946870-92-4
Molecular Weight:0
EC Number:1592732-453-0
Categories:
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,copper peptide
-
Location:
room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
-
Inquiry History56 Inquiries
Country Product Purchase Quantity Date Posted
United States
Best price Pure 98% LR3-IGF1 peptide IGF1 LR3 cas 946870-92-4
10 MT May 3, 2026
United States
YM 2024 High Quality Wholesale Price Peptides Factory Direct Supply IGF-1LR3 Powder CAS 946870-92-4
1111 MT Dec 18, 2025
United States
Wholesale 99% High Purity IGF-1 LR3 Lyophilized Powder CAS 946870-92-4 Factory Direct Supply
10 PCS Apr 9, 2026
France
IGF-1 LR3 High Purity Ig F-Lr3 Peptides Powder CAS 946870-92-4 with Competitive Price
5 Nov 1, 2023
Russia
igf-1 lr3
1 G Apr 22, 2025
Russia
Igf Lr3
10 MG Jun 6, 2026
United States
IGF-1 LR3
1 MT May 31, 2026
Canada
IGF-1 LR3
1 MG Mar 15, 2026
United States
IGF-1 LR3
10 MT Feb 23, 2026
United Kingdom
IGF-1 LR3
2 PCS Jan 21, 2026
Brazil
IGF-1 LR3
2 MG Jan 4, 2026
Canada
IGF-1R3
10 Dec 9, 2025
United States
Igf1 lr3
10 G Oct 16, 2024
Croatia
Igf-1 lr3
1 MT Oct 2, 2024
United States
IGF1-LR3
7.5 Feb 11, 2024
United States
IGF-1 LR3 99% powder Pharmacy Grade Top Purity Senwayer
3 MT Sep 18, 2023
Switzerland
IGF-LR3 Recombinant Human IGF-1 LR3 99%
20 Jul 29, 2026
United States
IGF-1LR3 Powder
1 G Jul 23, 2026
Brazil
IGF-1LR3
20 PCS Apr 17, 2026
United States
Igf-1 lr3
30 MG Feb 3, 2026 Post an enquiry for this product